LAB
NASDAQStockStandard BioTools Inc.
$0.93+0.00 (+0.47%)
52-Week Range
$0.92
$1.68
Key Stats
Market Cap
359.5M
P/E Ratio
—
Dividend Yield
—
Beta
1.37
Volume
1.6M
Avg Volume
3.0M
Performance
1M
-16.17%
3M
-38.38%
6M
-32.08%
YTD
-26.73%
1Y
-18.38%
3Y
-54.83%
5Y
-75.51%
Price Chart
ETF Exposure
LAB is held by 61 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
PreviousPage 2 of 2
About LAB ETF Exposure
Standard BioTools Inc. (LAB) is held by 61 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 359.5M, LAB is a widely held institutional stock. The stock currently trades at $0.93. Investors can gain exposure to LAB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LAB, sorted by portfolio weight.